Essity AB Series B (0RQD) fair value: what the stock is really worth
As of Oct 2, 2026: fair value of Essity AB Series B SEK 207, price SEK 256, upside -19.2%, quality 49 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch Essity AB Series B for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Oct 3, 2026.
How to read this chart
60‑month range kr 188.06 – kr 304.57 · fair‑value band kr 125.50 – kr 317.02 · the kr 256.00 price screens above the kr 206.83 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Oct 3, 2026.
Follow Essity AB Series B in your weekly email
Every Wednesday you see whether Essity AB Series B is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Essity AB (publ) develops, produces, and sells hygiene and health products and services in Europe, North and Latin America, Asia, and internationally. The company operates through three segments: Health & Medical, Consumer Goods, and Professional Hygiene.
Show more
Essity AB (publ) develops, produces, and sells hygiene and health products and services in Europe, North and Latin America, Asia, and internationally. The company operates through three segments: Health & Medical, Consumer Goods, and Professional Hygiene. The Health & Medical segment offers incontinence products, wound care, compression therapy, orthopedics, skincare products, and digital solutions with sensor technology under the TENA, Leukoplast, JOBST, Actimove, Cutimed, Delta-Cast, AquaCast Liner, and Hydrofera brands to family carers, professional caregivers, and patients and consumers through pharmacies, medical device stores, hospitals, distributors, care institutions, and e-commerce. The Consumer Goods segment provides pads, panty liners, tampons, diapers, wet wipes, shampoos, lotions, baby oil, skin creams, intimate soaps, intimate wipes, leakproof apparel, menstrual cups, toilet papers, household towels, handkerchiefs, facial tissues, and napkins under the TENA, Knix, Modibodi, Libero, Lotus, Libresse, Bodyform, Nana, Saba, Nosotras, TOM Organic, Tempo, Zewa, Cushelle, Plenty, Regio, and Familia brands through retail trade and e-commerce. The Professional Hygiene segment offers toilet papers, paper hand towels, napkins, hand soaps, hand lotions, hand sanitizers, dispensers, and cleaning and wiping products, as well as vision cleaning and data-driven cleaning solutions under the Tork brand to companies and office buildings, universities, healthcare facilities, airports, industries, restaurants, hotels, stadiums, and other public venues through direct to the end-customer, e-commerce, or distributors. Essity AB (publ) was founded in 1849 and is headquartered in Stockholm, Sweden.
Stock analysis
Essity AB Series B (0RQD) currently trades at kr 256.00, while our model-based Fair Value estimate is kr 206.83, 19.2% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Multiples group reads highest at a median of kr 204.68 per share, and 2 of the 23 models we run sit above the kr 256.00 price.
Bear case: the Asset-Based group reads lowest at kr 56.03, and 21 of the 23 models stay below the price. Evidence for this calculation is low.
Scenario range: kr 125.50 (bear) to kr 317.02 (bull), the price of kr 256.00 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 49/100 (below-average quality), in the Industrials sector.
Weak Growth: Revenue growth is weak: less than 2 % a year.
Essity AB Series B reported revenue of 122B SEK in FY2021 versus 109B SEK in FY2017, a compound +2.8%/yr. Reported net income was 8.6B SEK in FY2021, compounding +1.5%/yr from FY2017.
Key figures
Market cap 183B SEK (≈ $18.3B) · P/S ratio 1.33 · Dividend yield 3.4% · Net margin 7.1% · Return on equity 14.0% · Return on assets (EBIT) 8.5% · Operating margin 12.6% · Revenue (TTM) 138B SEK.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 52 out of 100 (low confidence).
What moves the price
The share trades about 10% below its 52-week high and 8% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Industrials peers we cover trades at −49% fair-value upside, at −19%, 0RQD screens cheaper than that median.
Fair Value models
Bear kr 125.50Fair Value kr 206.83Bull kr 317.02
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.40/100
Revenue growth is weak: less than 2 % a year.
Revenue growth 1 year
+0.1%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+0.9%
’17
’18
’19
’20
’21
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
10.9% (2017) → 10.8% (2021)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: no share-count history
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its sector: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median. (Industry “Paper Products” was too small, so the broader sector is used.)Industrials · 5311 stocks
Beats the sector median on 8/12 measures
Overall it ranks above its sector peers.
Valuation
Quality Score49 · Below median
Fair Value upside−19.2% · Below median
Profitability
Return on equity (TTM)14.0% · Above median
Return on assets6.6% · Top 25%
Net margin (TTM)8.8% · Above median
Operating margin (TTM)12.6% · Above median
Growth and dividend
Revenue growth2.6% · Below median
Dividend yield (TTM)3.4% · Above median
Balance sheet
Debt / equity0.79× · Highest 25%
Valuation Multiplesvs Industrials median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Essity AB Series B Fair Value". https://www.fairvalue-calculator.com/stock/0RQD
Frequently asked questions
Is Essity AB Series B (0RQD) overvalued or undervalued?
As of Oct 3, 2026, our model estimates a fair value of kr 206.83 versus a price of kr 256.00, about −19% upside (overvalued).
What is the fair value of 0RQD?
Our model-based fair value for Essity AB Series B is kr 206.83 (as of Oct 3, 2026), built from audited fundamentals. The current price: kr 256.00.
What is the quality score of 0RQD?
Essity AB Series B has a Quality Score of 49/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Essity AB Series B (0RQD)?
Our model-based price target is the fair value of kr 206.83 (as of Oct 3, 2026) from 23 valuation models. Cautious scenario kr 125.50, optimistic scenario kr 317.02. It is a calculation from audited fundamentals, not an analyst target.
What is the Essity AB Series B stock forecast for 2026?
Our models put fair value at kr 206.83, about −19% upside versus a price of kr 256.00 (overvalued). Cautious scenario kr 125.50, optimistic scenario kr 317.02. The calculation is refreshed regularly with new filings.
What is the revenue of Essity AB Series B (0RQD)?
Essity AB Series B reported trailing-twelve-month revenue of about 138B SEK (latest available figure, as of Oct 3, 2026).
Does Essity AB Series B pay a dividend?
Essity AB Series B currently shows a dividend yield of about 3.42% relative to its recent price (as of Oct 3, 2026).
What is the intrinsic value of Essity AB Series B (0RQD)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Essity AB Series B it is kr 206.83 per share (as of Oct 3, 2026), against a price of kr 256.00. It is the blended result of 23 valuation models (cash flow, earnings, asset, dividend).
Is Essity AB Series B stock overvalued or undervalued in 2026?
As of Oct 3, 2026, 0RQD trades above its calculated fair value: price kr 256.00, fair value kr 206.83, a gap of about −19% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 0RQD?
No. The price is what the market pays today (kr 256.00); the fair value is what the company's own numbers justify (kr 206.83). For Essity AB Series B the two are kr 49.17 per share apart. That gap is exactly why we show both numbers side by side.
How much is Essity AB Series B worth?
The market values Essity AB Series B at about 183B SEK (market capitalisation, as of Oct 3, 2026). Per share that is kr 256.00; our models calculate a fair value of kr 206.83 per share.
What do the bullish and bearish scenarios say about 0RQD?
Our models span a range for Essity AB Series B: cautious scenario kr 125.50, base kr 206.83, optimistic kr 317.02 per share (as of Oct 3, 2026, price kr 256.00). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Essity AB Series B (0RQD)?
Balance-sheet figures for Essity AB Series B (as of Oct 3, 2026): return on equity 14.0%, debt of 0.79 per unit of equity. They feed the Quality Score of 49/100, which measures business quality independently of the share price.
How far is 0RQD from its 52-week high?
Essity AB Series B trades at kr 256.00, about 10% below its 52-week high of kr 284.20 and 8% above the low of kr 237.63 (as of Oct 2, 2026). Distance from the high says nothing about value: that is what the fair value of kr 206.83 is for.
Which stocks are comparable to Essity AB Series B?
From the same area (Industrials) we also value NATHIND, GANGAPA, MOHITPPR, CELLA, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Essity AB Series B stock attractive at the current price?
The data as of Oct 3, 2026: price kr 256.00, calculated fair value kr 206.83 (−19%), Quality Score 49/100, from 23 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 0RQD calculated?
We run Essity AB Series B through 23 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of kr 206.83, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5 % above its aggregate fair value. Essity AB Series B itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Essity AB Series B (0RQD)?
The closing price on Oct 2, 2026 was kr 256.00. Our model-based fair value is kr 206.83, about −19% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Essity AB Series B right now?
Solid but not exceptional quality (49/100) and above fair value, neither a clear bargain nor a standout compounder. A fairly wide model range (kr 125.50 to kr 317.02) leaves room in how you read the outcome. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.
Key figures of Essity AB Series B
How large is the market capitalisation of Essity AB Series B (0RQD)?
The market capitalisation of Essity AB Series B is 183B SEK (≈ $18.3B). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Essity AB Series B (0RQD)?
The price-to-sales ratio of Essity AB Series B is 1.33 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What is the dividend yield of Essity AB Series B (0RQD)?
The dividend yield of Essity AB Series B is 3.4%. Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Essity AB Series B (0RQD)?
The net margin of Essity AB Series B is 7.1% (fiscal year 2021). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Essity AB Series B (0RQD)?
The return on equity (ROE) of Essity AB Series B is 14.0% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Essity AB Series B (0RQD)?
On an EBIT basis the return on assets of Essity AB Series B is 8.5% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Essity AB Series B (0RQD)?
The operating margin of Essity AB Series B is 12.6% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Essity AB Series B (0RQD)?
Revenue at Essity AB Series B is growing +2.6% versus a year earlier (3y avg +0.9%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Essity AB Series B (0RQD)?
Earnings per share at Essity AB Series B are growing −10.3% versus a year earlier. How much earnings per share grew versus a year earlier.
Free · no account needed
Watch Essity AB Series B in the live analysis
One click puts Essity AB Series B on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
